Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Jun-23 7:52 AM View:  | Scheeren Joseph Director | Barinthus Biotherapeutics P... (BRNS) | 26-Jun-23 | Private Purchase | 10,000 | $2.44 | $24,400.00 | 77% 13.0K to 23.0K | |
| 01-Jun-23 4:33 PM View: | Wright Robin Director | Barinthus Biotherapeutics P... (BRNS) | 25-May-23 | Private Purchase | 13,750 | $2.66 | $36,612.10 | 40% 34.51K to 48.26K | |
| 29-Mar-23 4:41 PM View: | Enright William Chief Executive Officer Director | Barinthus Biotherapeutics P... (BRNS) | 27-Mar-23 | Sale | 15,000 | $2.42 | $36,298.50 | (1%) 1.26M to 1.24M | |
| 04-Oct-22 1:01 PM View: | M&g Investment Management Ltd 10% Owner | Barinthus Biotherapeutics P... (BRNS) | 30-Sep-22 | Acquisition (other) | 4,108,750 | -- | -- | 377% 1.09M to 5.2M | |
| 04-Oct-22 1:03 PM View: | M&g Alternatives Investment... 10% Owner | Barinthus Biotherapeutics P... (BRNS) | 30-Sep-22 | Disposition (other) Duplicate | 4,108,750 | -- | -- | (100%) 4.11M to 0 | |
| 26-Aug-22 4:26 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 25-Aug-22 | Option Exercise | 39,176 | $0.00 | $15.67 | 52235% 75 to 39.25K | |
| 26-Aug-22 4:27 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 25-Aug-22 | Sale | 10,000 | $7.39 | $73,870.00 | (9%) 114.21K to 104.21K | |
| 26-Aug-22 4:26 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 25-Aug-22 | Option Sale | 39,176 | $6.57 | $257,396.00 | (100%) 39.25K to 75 | |
| 26-Aug-22 4:26 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 24-Aug-22 | Option Sale | 450 | $4.78 | $2,152.22 | (86%) 0.53K to 75 | |
| 26-Aug-22 4:26 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 24-Aug-22 | Option Exercise | 450 | $0.00 | $0.18 | 600% 75 to 0.53K | |
| 19-Aug-22 4:06 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 18-Aug-22 | Option Sale | 2,175 | $4.84 | $10,530.90 | (97%) 2.25K to 75 | |
| 19-Aug-22 4:06 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 18-Aug-22 | Option Exercise | 2,175 | $0.00 | $0.87 | 2900% 75 to 2.25K | |
| 19-Aug-22 4:05 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 17-Aug-22 | Sale | 500 | $4.76 | $2,381.00 | (< 1%) 114.71K to 114.21K | |
| 19-Aug-22 4:06 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 17-Aug-22 | Option Sale | 649 | $4.77 | $3,092.74 | (90%) 0.72K to 75 | |
| 19-Aug-22 4:06 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 17-Aug-22 | Option Exercise | 649 | $0.00 | $0.26 | 865% 75 to 0.72K | |
| 17-Aug-22 4:05 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 16-Aug-22 | Option Sale | 2,200 | $4.78 | $10,513.10 | (97%) 2.27K to 75 | |
| 17-Aug-22 4:05 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 16-Aug-22 | Option Exercise | 2,200 | $0.00 | $0.88 | 2933% 75 to 2.27K | |
| 17-Aug-22 4:05 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 16-Aug-22 | Sale | 1,220 | $4.82 | $5,876.37 | (1%) 115.93K to 114.71K | |
| 17-Aug-22 4:05 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 15-Aug-22 | Option Sale | 5,350 | $4.76 | $25,463.30 | (99%) 5.42K to 75 | |
| 17-Aug-22 4:05 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 15-Aug-22 | Option Exercise | 5,350 | $0.00 | $2.14 | 7133% 75 to 5.42K | |
| 17-Aug-22 4:05 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 15-Aug-22 | Sale | 2,400 | $4.75 | $11,407.20 | (2%) 118.33K to 115.93K | |
| 15-Aug-22 4:41 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 12-Aug-22 | Sale | 5,000 | $4.50 | $22,500.00 | (4%) 123.33K to 118.33K | |
| 15-Jul-22 4:06 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 28-Jun-22 | Option Sale | 5 | $6.00 | $30.00 | (6%) 80 to 75 | |
| 15-Jul-22 4:06 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 28-Jun-22 | Option Exercise | 5 | $0.00 | $0.00 | 7% 75 to 80 | |
| 15-Jul-22 4:05 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 24-Jun-22 | Acquisition (small) | 100 | $5.87 | $586.80 | < 1% 123.23K to 123.33K | |
| 15-Jul-22 4:05 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 23-Jun-22 | Option Exercise | 7,338 | $0.00 | $2.94 | 6% 115.9K to 123.24K | |
| 15-Jul-22 4:05 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 23-Jun-22 | Option Sale | 8 | $5.28 | $42.24 | (< 1%) 123.24K to 123.23K | |
| 04-Apr-22 4:31 PM View: | Scheeren Joseph Director | Barinthus Biotherapeutics P... (BRNS) | 01-Apr-22 | Private Purchase | 10,000 | $5.09 | $50,900.00 | 333% 3.0K to 13.0K | |
| 04-Apr-22 4:30 PM View: | Hammacher Alex Director | Barinthus Biotherapeutics P... (BRNS) | 31-Mar-22 | Private Purchase | 2,000 | $5.14 | $10,280.00 | 200% 1.0K to 3.0K | |
| 04-Jan-22 4:05 PM View: | Hammacher Alex Director | Barinthus Biotherapeutics P... (BRNS) | 31-Dec-21 | Market Purchase | 1,000 | $10.86 | $10,860.00 | 100% 0 to 1.0K | (2%) |
| 23-Dec-21 4:06 PM View: | Wright Robin Director | Barinthus Biotherapeutics P... (BRNS) | 22-Dec-21 | Market Purchase | 10,000 | $9.97 | $99,700.00 | 41% 24.51K to 34.51K | (5%) |
| 11-Feb-22 10:00 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 17-Dec-21 | Option Exercise | 115,799 | $0.00 | $46.32 | 115799% 100 to 115.9K | |
| 06-May-21 4:25 PM View: | Oxford Sciences Innovation ... 10% Owner | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Purchase | 600,000 | $17.00 | $10,200,000.00 | 4% 16.4M to 17.0M | |
| 06-May-21 4:27 PM View: | Ellis Christopher Chief Operating Officer | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Purchase | 75 | $17.00 | $1,275.00 | 100% 0 to 75 | |
| 06-May-21 4:25 PM View: | Phillips Anne M. Director | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Purchase | 3,000 | $17.00 | $51,000.00 | 100% 0 to 3.0K | |
| 06-May-21 4:28 PM View: | Griffiths Graham Chief Business Officer | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Purchase | 100 | $17.00 | $1,700.00 | 100% 0 to 100 | |
| 06-May-21 4:29 PM View: | Dawes Karen A Director | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Purchase | 1,700 | $17.00 | $28,900.00 | 100% 0 to 1.7K | |
| 06-May-21 4:28 PM View: | Wright Robin Director | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Purchase | 14,000 | $17.00 | $238,000.00 | 133% 10.51K to 24.51K | |
| 06-May-21 4:26 PM View: | Scheeren Joseph Director | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Purchase | 3,000 | $17.00 | $51,000.00 | 100% 0 to 3.0K | |
| 06-May-21 4:25 PM View: | Oxford Sciences Innovation ... 10% Owner | Barinthus Biotherapeutics P... (BRNS) | 04-May-21 | Conversion | 8,197,770 | -- | -- | 100% 8.2M to 16.4M | |
| 03-May-21 3:20 PM View: | M&g Investment Management Ltd 10% Owner | Barinthus Biotherapeutics P... (BRNS) | 30-Apr-21 | Purchase | 125,000 | $14.40 | $1,800,000.00 | 13% 963.6K to 1.09M | |
| 04-May-21 8:24 PM View: | Enright William Chief Executive Officer Director | Barinthus Biotherapeutics P... (BRNS) | 29-Apr-21 | Grant | 455,775 | -- | -- | 61% 743.46K to 1.2M |
